Jeena Sikho Lifecare Limited has informed the Exchange regarding 'Publication of Case Study/Research Articles'.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare has informed the stock exchange about the publication of six case studies authored by its Managing Director Acharya Manish Ji (Manish Grover) along with associated doctors and Ayurvedic professionals. The articles, published in the International Journal of Diagnostics and Research (IJDR, Volume 2, Issue 4, Impact Factor 1.013) on July 15, 2025, cover Ayurvedic management of chronic kidney disease, Grade 3 fatty liver, diabetes, chronic psoriasis, and adenomyosis. Each case study documents patient treatment outcomes at the company's hospitals in Derabassi and Baltana, including measurable improvements in kidney function, liver size, and quality-of-life scores. The disclosure was made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements on July 30, 2025.
This is a brand-building and credibility announcement rather than a material business event. It may modestly support the company's positioning in the Ayurvedic treatment market but is unlikely to cause any direct movement in the stock price or affect near-term financials.